NorthStar Node of the Clinical Trials Network

临床试验网络的 NorthStar 节点

基本信息

批准号：
10056402
负责人：
GAVIN BART
金额：
$ 64.66万
依托单位：
HENNEPIN HEALTHCARE RESEARCH INSTITUTE
依托单位国家：
美国
项目类别：
财政年份：
2015
资助国家：
美国
起止时间：
2015-09-01 至 2025-02-28
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10056402
关键词：
Address Adoption Alcohol or Other Drugs use Algorithms American Artificial Intelligence Big Data Cannabis Cardiovascular Diseases Caring Childhood Chronic Chronic Disease Clinic Clinical Clinical Research Clinical Sciences Clinical Treatment Clinical Trials Network Communities Comparative Effectiveness Research Counseling County Criminal Justice Data Science Development Diagnosis Disease Disease Outcome Dose Drug Kinetics Drug abuse Drug user Electronic Health Record Ensure Federally Qualified Health Center Fellowship Program Guidelines HIV Health Health Personnel Health Services Research Health system Healthcare Homelessness Housing Human Resources Infrastructure Institutes Institution Integrated Health Care Systems Intervention Iowa Learning Machine Learning Major Depressive Disorder Medical Medicine Mental disorders Mentors Methamphetamine Midwestern United States Minnesota Mission Modeling Multi-Institutional Clinical Trial National Institute of Drug Abuse Natural Language Processing Neurosciences North Dakota Opioid Outcome Patient Care Patient-Focused Outcomes Patients Pharmaceutical Preparations Policies Population Population Heterogeneity Positioning Attribute Primary Health Care Protocols documentation Psychiatry Public Health Informatics Randomized Controlled Trials Recovery Research Research Personnel Rural SECTM1 gene Scientist Site Social Work South Dakota Student Health Services Substance Use Disorder Sum System Technology Transfer Testing Training Training Programs Translating Translational Research Translations Treatment outcome Underrepresented Minority Universities Viral hepatitis Wisconsin Workforce Development addiction adolescent health base career clinical practice cognitive training collaborative care community based participatory research comorbidity evidence base health care service utilization illicit drug use implementation science improved innovation machine learning algorithm medical specialties methamphetamine use novel therapeutic intervention novel therapeutics personalized medicine pragmatic trial precision medicine predictive modeling research and development research data dissemination rural area safety net screening special interest group treatment program university student urban Native American urban area working group

项目摘要

Since joining the NIDA National Drug Abuse Treatment Clinical Trials Network (CTN) in 2015, the NorthStar Node has made significant contributions to the objectives and priorities of the CTN. The NorthStar Node and its investigators have led or co-led five CTN protocols, served as a research site for seven CTN studies, co- chaired the CTN Steering Committee and the Data Science Work Group, served on the Research Development Committee, and contributed to several special interest groups. The NorthStar Node's research portfolio includes traditional randomized controlled trials (CTN-0068), pragmatic comparative effectiveness research (CTN-0098A and CTN-0099), implementation science (CTN-0074, CTN-0098B, and CTN-0099), community-based participatory research (CTN-0096), data science (CTN-0076 and CTN-0087), and health services research (CTN-0070). In this application, the NorthStar Node has seven guiding objectives (POLARIS): 1) generating evidence that informs Policy and clinical guidelines; 2) evaluating models addressing co-Occurring SUD and medical and psychiatric conditions; 3) using principals of a Learning health system to conduct pragmatic trials; 4) using Artificial intelligence and other data sciences approaches to enhance SUD research and care; 5) Reaching understudied populations to ensure SUD research is relevant to diverse populations; 6) using Implementation science to test the integration of evidence-based SUD practices into general medical settings; and 7) testing innovative Strategies for SUD treatment. Potential studies to meet these objectives include 1) a novel therapeutic intervention for methamphetamine use disorder; 2) development of machine learning algorithms in the electronic health record to target substance use screening and enhance substance use disorder diagnoses; 3) precision/personalized medicine studies using population pharmacokinetics to better define and refine medication dosing strategies that improve treatment outcome; and 4) testing collaborative care models to address co-occurring chronic medical illnesses in specialty addiction treatment settings. Our expertise spans multi-site clinical trials, implementation science, community-based participatory research, EHR-based interventions, machine learning and natural language processing, and health services research. In addition to community partners that include urban and rural integrated health systems, federally qualified health centers serving underrepresented minorities, specialty addiction treatment programs, and pediatric and adolescent health clinics, the NorthStar Node brings affiliated research and dissemination networks into the CTN, including CTSA, SIREN, PCORNet, JCOIN, HOPE, the Network Coordinating Office of the Addiction Technology Transfer Centers, a learning health system training program (K12), three NIDA training programs (T32), and fellowship programs in addiction medicine and addiction psychiatry. The NorthStar Node is well situated to address current and emerging SUD issues and advance research in the field in order to improve patient outcome and transform health systems.

自2015年加入NIDA国家药物滥用治疗临床试验网络（CTN）以来，NorthStar Node 为 CTN 的目标和优先事项做出了重大贡献。北极星节点及其研究人员领导或共同领导了五项 CTN 协议，作为七项 CTN 研究的研究地点，共同担任 CTN 指导委员会和数据科学工作组主席，负责研究发展委员会，并为几个特殊利益团体做出了贡献。北极星节点的研究组合包括传统的随机对照试验（CTN-0068）、务实的比较有效性研究（CTN-0098A 和 CTN-0099）、实施科学（CTN-0074、CTN-0098B 和 CTN-0099）、基于社区的参与性研究 (CTN-0096)、数据科学（CTN-0076 和 CTN-0087）以及健康服务研究（CTN-0070）。在此应用程序中，NorthStar 节点有七个指导目标 (POLARIS)：1) 生成为政策和临床指南提供信息的证据； 2）评估模型解决同时发生的 SUD 以及医疗和精神疾病； 3）运用学习健康的原则建立务实试验制度； 4）利用人工智能和其他数据科学方法加强 SUD 研究和护理； 5) 覆盖未充分研究的人群，确保 SUD 研究与以下领域相关：不同的人群； 6) 使用实施科学来测试基于证据的 SUD 实践的整合进入一般医疗环境； 7) 测试 SUD 治疗的创新策略。需要满足的潜在研究这些目标包括 1) 针对甲基苯丙胺使用障碍的新型治疗干预措施； 2）开发电子健康记录中的机器学习算法以进行药物使用筛查并加强药物滥用障碍的诊断； 3）利用人群进行精准/个性化医学研究药代动力学，以更好地定义和完善药物剂量策略，从而改善治疗结果；和 4) 测试协作护理模式以解决专业成瘾中同时发生的慢性疾病治疗设置。我们的专业知识涵盖多中心临床试验、实施科学、基于社区的参与性研究、基于电子病历的干预措施、机器学习和自然语言处理，以及卫生服务研究。除了包括城乡一体化医疗卫生在内的社区合作伙伴系统、为代表性不足的少数群体提供服务的联邦合格医疗中心、专业成瘾治疗项目以及儿科和青少年健康诊所，北极星节点带来了附属研究和 CTN 的传播网络，包括 CTSA、SIREN、PCORNet、JCOIN、HOPE、the Network 成瘾技术转移中心协调办公室，学习健康系统培训计划 (K12)、三个 NIDA 培训计划 (T32) 以及成瘾医学和成瘾研究金计划精神病学。北极星节点处于有利地位，可以解决当前和新兴的 SUD 问题并推进领域的研究，以改善患者的治疗结果并转变卫生系统。